Who better to describe life at Servier than the people who live it every day? ✨ Meet Elodie 🇫🇷, one of our 10 career ambassadors selected by colleagues across the Group. In her interview, she shares her journey, what gives meaning to her work, and what keeps her moving forward. 💬 “I care about my mission with passion, we care for patients with innovation.” 👉 f.mtr.cool/yxesy7w5la #WeAreServier #MovedByYou #CareerStories #CareerJourney

🔬 Today on #FragileXAwarenessDay, we reaffirm our commitment to advancing research in rare neurological disorders. Fragile X syndrome, caused by a change in the FMR1 gene, is one of the leading known genetic causes of autism spectrum disorder and affects ~1 in 7,000 males and 1 in 11,000 females. At Servier, we aim to become a global leader in rare neuro diseases by 2030 and strengthened this ambition in 2025 with the acquisition of a potential Fragile X treatment.  Learn more about Fragile X syndrome 🔗 f.mtr.cool/vpnyhtw9qr #WeAreServier #MovedByYou #RareDiseases #Neurology #FragileXSyndrome

🇦🇺 What makes a career meaningful? For Sarah, it’s the people, experiences and purpose that shape her journey at Servier. As one of our career ambassadors, she shares what drives her forward every day. 💬 “I grow my knowledge every day, we grow hope every step of the way.” 🎥 Discover Sarah’s story: f.mtr.cool/q1x6r33v4v #WeAreServier #MovedByYou #CareerStories #CareerJourney #PurposeAtWork

🧬 During #BeckerMuscularDystrophy Awareness Week, we reaffirm our commitment to people living with rare neuromuscular diseases. Becker muscular dystrophy is one of the areas where significant unmet medical needs remain. we are committed to advancing research in rare neurological disorders and addressing unmet patient needs. At Servier, our ambition is to become a global leader in rare neurological diseases by 2030.  Learn more about Becker muscular dystrophy 🔗 f.mtr.cool/i6vt63lbyc #WeAreServier #MovedByYou #RareDisease #Neurology

🏠 With @Techo  and the support of Mécénat Servier, 12 emergency houses have been built across Argentina, Brazil, Colombia, Ecuador, Mexico and Panama. More than shelter, these homes bring safety, dignity and hope to families facing extreme poverty. Built together by volunteers and beneficiary families, they show the power of collective action. 🎥 Discover the impact in Brazil and across Latin America: f.mtr.cool/2ykguw7jy0 #WeAreServier #MovedByYou #MecenatServier #Solidarity

#EANS2026 has come to an end! We were delighted to connect with the European and international neurosurgical community, share perspectives, and discuss the challenges and opportunities ahead in neuroscience. In line with our #Servier2030 strategy, we invest close to 70% of our R&D budget in oncology research 🔬, with a particular focus on cancers where significant unmet medical needs remain. Learn more about our commitment to oncology 🔗 f.mtr.cool/b8j8u8ezz4 #WeAreServier #MovedByYou #Neuroscience #Neurosurgery @EANSonline50

🌏 First time at #WMS2026 in Hiroshima! More than a congress presence, it marks another step in our commitment to the rare neurology community.  At Servier, the acquisition of @EdgewiseTx 's Muscular Dystrophy Business strengthens our commitment to rare neurological disorders and advancing innovation for people living with Duchenne and Becker muscular dystrophies. 🔗 f.mtr.cool/9ok9vcrviw #WMS2026 #neurology #WeAreServier #MovedByYou

The #EASD2026 Congress is now over! We were pleased to share insights with the global community into advances in #diabetes research and care. #T2D #innovation #DiabetesCare @EASDnews 🔗 Read more about our commitments in diabetes 👉 f.mtr.cool/4ouvav0akm

💬 “I make an impact with my expertise, we make an impact in rare diseases.” What keeps you moving forward in your career? For Qiang in China 🇨🇳, it’s the opportunity to learn, contribute and make a difference alongside passionate colleagues. As one of our career ambassadors, he shares an authentic perspective on life at Servier. 👉 Read Qiang’s story: f.mtr.cool/r9he17gx9g #WeAreServier #MovedByYou #CareerStories #CareerJourney

We’re attending #EANS2026 in Hamburg, one of Europe’s largest neurosurgery congresses, bringing together 2,500+ experts from around the world. Visit us at Booth #23 and join our symposium to explore advances in neuroscience and patient care. At Servier, nearly 70% of our R&D investment is dedicated to oncology, advancing targeted therapies for cancers including glioma, cholangiocarcinoma and colorectal cancer. 🎗️ 🔗 f.mtr.cool/45kt0avi9o #WeAreServier #MovedByYou #Neurosurgery #Neuroscience @EANSonline50

❤️ Today is #WorldHeartDay Cardiovascular health starts with prevention. At Servier, a global leader in hypertension and a major player in cardiology, we’ve been committed to improving the lives of people living with cardiovascular diseases for over 70 years. From prevention to treatment adherence and innovation, we’re helping people live healthier lives. Learn more 👉 f.mtr.cool/98xegghaxt #WeAreServier #MovedByYou #CardiovascularHealth

Attending #EASD2026? Don’t forget to join our symposium “Early combination therapy in Type 2 diabetes: harmonizing glycemic control & cardiorenal protection.” 👇 🗓️ Today at 6:00 - 6:30 pm (CEST) Find out more at our booth – No. T.02 #T2D #innovation #DiabetesCare @EASDnews 🔗 Read more about our commitments in diabetes 👉 f.mtr.cool/kw5hh1anex

🌟 We’re attending the #EASD2026 Congress in Milan! 🎉 Join us to explore our latest innovations in #diabetes care. Visit our booth – No. T.02 – to connect and collaborate!  #T2D #innovation #DiabetesCare @EASDnews 🔗 Read more about our commitments in diabetes 👉 f.mtr.cool/266zxtcgvv

🧠 Today is #InternationalAtaxiaAwarenessDay!  Ataxia can affect essential functions like balance, coordination, speech, and eye movement.  🌍 Hereditary ataxia affects approximately 6 in 100,000 people worldwide.  👉 Raising awareness is key to improving early diagnosis and care. 👉 Early recognition can help guide diagnosis. Learn more: f.mtr.cool/w70slhl2n3  #WeAreServier #MovedByYou #InternationalAtaxiaAwarenessDay

Ready for #EANO2026 in Rome 🇮🇹? From 24-27 Sept, meet the Servier team at booth #1 and join our scientific symposiums. We’re committed to advancing oncology innovation and developing targeted therapies for cancers including glioma, cholangiocarcinoma, and colorectal cancer. Close to 70% of our R&D investment supports oncology research. Learn more: f.mtr.cool/fqj4sustzh @EANOassociation #EANO2026 #NeuroOncology #Oncology #CancerResearch #RareCancers #Innovation #PatientsFirst

Why is patient education critical to treatment success? When patients understand the benefits of consistent therapy and the risks of poor disease control, they are more likely to stay engaged and adhere to treatment plans. #TakeYourMedicine #TakeControl #HypertensionAwareness #AsOne #BecauseIsayso #BloodPressure

💬 “I care about my mission with passion, we care for patients with innovation.” From Colombia, Paula brings her energy and perspective to our collective story. 🇨🇴🌍 As one of our career ambassadors, she shares what inspires her journey at Servier and the impact of collaboration across borders. 🎥 Discover Paula’s story: f.mtr.cool/cv8xcmi47e #WeAreServier #MovedByYou #CareerStories #CareerJourney #PurposeAtWork

Missing a dose is rarely just about forgetting. Patients may struggle with adherence because they are concerned about side effects, do not fully understand the importance of daily treatment, or underestimate the impact of missed doses. That's why meaningful patient conversations are key to uncovering and addressing the barriers behind nonadherence. 💡 #TakeYourMedicine #BloodPressure #TakeYourMedicine #TakeControl #HypertensionAwareness #AsOne #BecauseIsayso

✨ It’s not just about what we do. It’s about why and how we do it. At Servier, every challenge is a chance to learn, innovate and make a meaningful impact for patients. Meet Sarah and Elodie, two of our employer brand ambassadors, and discover how purpose, resilience and collaboration shape their journey. 💙🌍 Ready to be moved by what matters? 👉 f.mtr.cool/7m2uvrwhhn #WeAreServier #MovedByYou #CareerStories #PurposeAtWork #CareerJourney

🔬 We’re excited to collaborate with @Cure51 to uncover new therapeutic targets in glioblastoma (GBM). By combining Cure51’s unique insights from glioblastoma survivors with our R&D expertise, we aim to identify breakthrough biological mechanisms that could lead to new treatment options for patients. This research partnership reflects our commitment to advancing innovation in oncology. 🔗 Read more: f.mtr.cool/q6r1oh9e54 #WeAreServier #MovedByYou #Oncology #Glioblastoma #GBM